BioX2 (Biological Exploration Payload 2) is targeted for launch to the International Space Station (ISS) in October 2022 to be a technological demonstration for biological sample automation, nucleic acid extraction, and nanopore sequencing in space. A stretch goal is to perform end-to-end operations on orbit and measure Darwinian evolution of Bacillus subtilis, which will help advance future space life detection missions.
Featured